Description:
GlidePath 13F Long-Term Hemodialysis Catheter by Bard Peripheral Vascular Inc
The GlidePath 13F Long-Term Hemodialysis Catheter is a specialized medical device designed and manufactured by Bard Peripheral Vascular Inc. This device has been primarily devised to aid in long-term hemodialysis treatment, a crucial therapeutic procedure for patients with kidney disease or dysfunction. The device serves as a reliable conduit for carrying out the filtration process, which is necessary when the kidneys fail to filter waste products independently.
This catheter's design highlights its benefits - the advanced, robust 13F size offers the required structure to sustain and facilitate long-term hemodialyis. It allows for optimal blood flow during the dialysis treatment while minimizing the potential risk of blood clotting or the introduction of air into the circulatory system.
Another notable advantage of the GlidePath 13F Long-Term Hemodialysis Catheter is the ease of insertion it provides. It has been designed so it can be implanted with minimal discomfort to the patient, while also reducing the risk of potential complications often associated with catheter placement.
In essence, the GlidePath 13F Long-Term Hemodialysis Catheter by Bard Peripheral Vascular Inc exemplifies state-of-the-art medical technology that combines efficacy, safety, and patient comfort, making it a trusted choice for long-term hemodialysis treatment.
How It Works:
Understanding the GlidePath 13F Long-Term Hemodialysis Catheter
The
GlidePath 13F Long-Term Hemodialysis Catheter is an innovation in the field of renal medicine, specifically designed to facilitate long-term vascular access for hemodialysis.
It incorporates an array of features aimed at improving patient comfort, reducing complications and enhancing the efficacy of the dialysis treatment.
Mechanism of Operation
The hemodialysis catheter is inserted into a major blood vessel - typically the internal jugular, subclavian or femoral veins. The catheter's twin-lumen design permits simultaneous blood withdrawal and return during hemodialysis, promoting efficient toxin removal and blood replenishment. This design may also reduce the risk of recirculation - a common issue with single-lumen devices.
Special Features:
The GlidePath catheter boasts several notable features that distinguish it from its counterparts:
Smooth Catheter Material:
The device is composed of a biocompatible and durable polyurethane material. Not only does this reduce patient discomfort, but it minimizes the threat of possible allergic reactions, inflammation, and infection.
Flexible Tip:
The catheter tip is designed to be highly flexible, reducing the risk of vessel damage during insertion and long-term use.
Numerous Exit Ports:
Multiple exit ports are strategically placed at the distal tip, creating a flow pattern that optimizes blood exchange. This results in efficient and effective dialysis treatments.
In conclusion, the GlidePath 13F Long-Term Hemodialysis Catheter brings together an assortment of features, laying a strong foundation for improved patient outcomes. The thoughtful design aids healthcare professionals in providing superior care to patients undergoing long-term hemodialysis. As medical professionals, adopting innovative technologies that enhance patient treatment options is crucial to advancing healthcare practices.